CHINARES PHARMA (03320) has successfully issued 1.1 billion yuan in corporate bonds.
China Resources Pharmaceutical Group Limited (03320) announced that the first tranche of 2025 corporate bonds with a total principal amount of 1.1 billion yuan has been issued...
(Note: The company name "" is translated as "China Resources Pharmaceutical Group Limited" in this context.)
CHINARES PHARMA (03320) announced that the first tranche of 2025 corporate bonds with a total principal amount of 1.1 billion yuan has been issued, with a term of three years and a coupon rate of 1.82% per annum. The net proceeds will be used for productive expenses, including repaying corporate debts, supplementing working capital, project development and operational expenses, investments related to technological innovation, and other purposes in compliance with applicable laws and regulations.
Related Articles
US Stock Market Move | Amazon.com, Inc. (AMZN.US) is up more than 2%, with the company accelerating its automation process.
US Stock Market Move | Halliburton (HAL.US) rose more than 9% with Q3 results exceeding expectations.
ANHUIEXPRESSWAY(00995) plans to invest approximately 3.0187 billion yuan to acquire 7% equity of Shandong Hi-speed(600350.SH)
US Stock Market Move | Amazon.com, Inc. (AMZN.US) is up more than 2%, with the company accelerating its automation process.
US Stock Market Move | Halliburton (HAL.US) rose more than 9% with Q3 results exceeding expectations.
ANHUIEXPRESSWAY(00995) plans to invest approximately 3.0187 billion yuan to acquire 7% equity of Shandong Hi-speed(600350.SH)
RECOMMEND
Why European Automakers Are Opposing Dutch Sanctions
20/10/2025
Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025
Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025
